Your browser doesn't support javascript.
loading
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project.
Usmani, Saad Z; Hoering, Antje; Cavo, Michele; Miguel, Jesus San; Goldschimdt, Hartmut; Hajek, Roman; Turesson, Ingemar; Lahuerta, Juan Jose; Attal, Michel; Barlogie, Bart; Lee, Jae Hoon; Kumar, Shaji; Lenhoff, Stig; Morgan, Gareth; Rajkumar, S Vincent; Durie, Brian G M; Moreau, Philippe.
Afiliação
  • Usmani SZ; Hematogic Oncology and Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC, United States. saad.usmani@atriumhealth.org.
  • Hoering A; Cancer Research and Biostatistics, Seattle, Washington, United States.
  • Cavo M; Seragnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.
  • Miguel JS; Centro de Investigación Médica Aplicada, IDISNA, CIBERONC, Clinica Universidad de Navarra, Pamplona, Spain.
  • Goldschimdt H; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Hajek R; University Hospital Ostrava and the Faculty of Medicine, CRAB, University of Ostrava Adam Rosenthal, Seattle, United States.
  • Turesson I; Department of Hematology, Malmo University Hospital, Malmo, Sweden.
  • Lahuerta JJ; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Attal M; Service d'Hématologie, CHU de Toulouse-Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.
  • Barlogie B; Hematology, Mount Sinai University, New York, United States.
  • Lee JH; Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, Republic of Korea.
  • Kumar S; Department of Internal Medicine, Division of Hematology, Mayo clinic, Rochester, MN, United States.
  • Lenhoff S; Skane University Hospital, Lund, Sweden.
  • Morgan G; MIRT, UAMS, Myeloma Insitute, Little Rock, United States.
  • Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN, United States.
  • Durie BGM; Hematology/Oncology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, United States.
  • Moreau P; service d'Hematologie, CHU de Nantes, Nantes, France.
Blood Cancer J ; 8(12): 123, 2018 11 23.
Article em En | MEDLINE | ID: mdl-30470751
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Blood Cancer J Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Blood Cancer J Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos